3B Blackbio Dx Statistics
Total Valuation
3B Blackbio Dx has a market cap or net worth of INR 14.16 billion. The enterprise value is 13.99 billion.
| Market Cap | 14.16B |
| Enterprise Value | 13.99B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Sep 19, 2025 |
Share Statistics
3B Blackbio Dx has 8.57 million shares outstanding. The number of shares has increased by 2.01% in one year.
| Current Share Class | 8.57M |
| Shares Outstanding | 8.57M |
| Shares Change (YoY) | +2.01% |
| Shares Change (QoQ) | -1.72% |
| Owned by Insiders (%) | 47.56% |
| Owned by Institutions (%) | 3.82% |
| Float | 2.78M |
Valuation Ratios
The trailing PE ratio is 28.78.
| PE Ratio | 28.78 |
| Forward PE | n/a |
| PS Ratio | 13.61 |
| PB Ratio | 4.66 |
| P/TBV Ratio | 4.75 |
| P/FCF Ratio | 39.89 |
| P/OCF Ratio | 37.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.04, with an EV/FCF ratio of 39.42.
| EV / Earnings | 28.43 |
| EV / Sales | 13.45 |
| EV / EBITDA | 28.04 |
| EV / EBIT | 28.85 |
| EV / FCF | 39.42 |
Financial Position
The company has a current ratio of 6.25, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.25 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 428.04 |
Financial Efficiency
Return on equity (ROE) is 17.78% and return on invested capital (ROIC) is 13.42%.
| Return on Equity (ROE) | 17.78% |
| Return on Assets (ROA) | 9.94% |
| Return on Invested Capital (ROIC) | 13.42% |
| Return on Capital Employed (ROCE) | 15.41% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | 12.24M |
| Profits Per Employee | 5.79M |
| Employee Count | 85 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, 3B Blackbio Dx has paid 166.06 million in taxes.
| Income Tax | 166.06M |
| Effective Tax Rate | 25.23% |
Stock Price Statistics
The stock price has decreased by -15.98% in the last 52 weeks. The beta is 0.30, so 3B Blackbio Dx's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -15.98% |
| 50-Day Moving Average | 1,390.43 |
| 200-Day Moving Average | 1,500.17 |
| Relative Strength Index (RSI) | 64.46 |
| Average Volume (20 Days) | 7,334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 3B Blackbio Dx had revenue of INR 1.04 billion and earned 492.17 million in profits. Earnings per share was 57.41.
| Revenue | 1.04B |
| Gross Profit | 754.58M |
| Operating Income | 484.97M |
| Pretax Income | 658.19M |
| Net Income | 492.17M |
| EBITDA | 499.02M |
| EBIT | 484.97M |
| Earnings Per Share (EPS) | 57.41 |
Balance Sheet
The company has 227.67 million in cash and 2.62 million in debt, with a net cash position of 225.05 million or 26.27 per share.
| Cash & Cash Equivalents | 227.67M |
| Total Debt | 2.62M |
| Net Cash | 225.05M |
| Net Cash Per Share | 26.27 |
| Equity (Book Value) | 3.04B |
| Book Value Per Share | 355.75 |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was 373.45 million and capital expenditures -18.53 million, giving a free cash flow of 354.92 million.
| Operating Cash Flow | 373.45M |
| Capital Expenditures | -18.53M |
| Free Cash Flow | 354.92M |
| FCF Per Share | 41.42 |
Margins
Gross margin is 72.54%, with operating and profit margins of 46.62% and 47.31%.
| Gross Margin | 72.54% |
| Operating Margin | 46.62% |
| Pretax Margin | 63.27% |
| Profit Margin | 47.31% |
| EBITDA Margin | 47.97% |
| EBIT Margin | 46.62% |
| FCF Margin | 34.12% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.24%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.24% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 6.95% |
| Buyback Yield | -2.01% |
| Shareholder Yield | -1.76% |
| Earnings Yield | 3.48% |
| FCF Yield | 2.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |